Filing Details
- Accession Number:
- 0001209191-17-057661
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2017-10-20 17:12:28
- Reporting Period:
- 2017-10-12
- Accepted Time:
- 2017-10-20 17:12:28
- Original Submission Date:
- 2017-10-17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178879 | Amicus Therapeutics Inc | FOLD | Pharmaceutical Preparations (2834) | 200422823 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1400973 | F John Crowley | C/O Amicus Therapeutics, Inc. 1 Cedar Brook Drive Cranbury NJ 08512 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-10-12 | 380,000 | $14.25 | 708,001 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-10-12 | 380,000 | $14.25 | 328,001 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-10-13 | 22,160 | $14.75 | 350,161 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-10-13 | 22,160 | $14.75 | 328,001 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-10-16 | 47,135 | $14.75 | 375,136 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-10-16 | 47,135 | $14.75 | 328,001 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right to buy) | Disposition | 2017-10-12 | 5,783 | $0.00 | 5,783 | $6.45 |
| Common Stock | Stock Options (right to buy) | Disposition | 2017-10-12 | 13,622 | $0.00 | 13,622 | $4.38 |
| Common Stock | Stock Options (right to buy) | Disposition | 2017-10-12 | 3,462 | $0.00 | 3,462 | $3.53 |
| Common Stock | Stock Options (right to buy) | Disposition | 2017-10-12 | 165,000 | $0.00 | 165,000 | $2.52 |
| Common Stock | Stock Options (right to buy) | Disposition | 2017-10-12 | 192,133 | $0.00 | 192,133 | $3.19 |
| Common Stock | Stock Options (right to buy) | Disposition | 2017-10-13 | 22,160 | $0.00 | 22,160 | $3.53 |
| Common Stock | Stock Options (right to buy) | Disposition | 2017-10-16 | 47,135 | $0.00 | 47,135 | $3.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 131,024 | 2016-02-15 | 2022-02-15 | No | 4 | M | Direct |
| 136,378 | 2016-06-04 | 2022-06-04 | No | 4 | M | Direct |
| 161,538 | 2017-01-28 | 2023-01-28 | No | 4 | M | Direct |
| 0 | 2017-06-18 | 2023-06-18 | No | 4 | M | Direct |
| 20,972 | 2015-01-03 | 2024-01-03 | No | 4 | M | Direct |
| 139,378 | 2017-01-28 | 2023-01-28 | No | 4 | M | Direct |
| 92,243 | 2017-01-28 | 2023-01-28 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 64,895 | Direct |
Footnotes
- The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017.
- This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.09 to $14.44. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.09 to $14.44. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.75 to $14.79. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.75 to $14.79. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
